dr. blachly discusses ctdna as a biomarker in hairy cell leukemia
Published 4 years ago • 188 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:50
expert identifies potential biomarkers for hairy cell leukemia
-
1:19
dr. taylor on ongoing phase ii of frontline vemurafenib combo in hairy cell leukemia
-
1:19
dr. taylor on ongoing phase ii trial of frontline vemurafenib combo in hairy cell leukemia
-
2:18
dr. kreitman on mrd-negative crs with moxetumomab pasudotox in hairy cell leukemia
-
3:09
redlamp 4: circulating tumor dna & ct monitoring for untreated dlbcl - a correlative biomarker study
-
1:10
expert discusses the safety of vemurafenib
-
1:21
dr. pinilla-ibarz on the fda approval of moxetumomab pasudotox in hairy cell leukemia
-
0:36
transplantation in ctcl
-
0:32
patient selection for ctcl
-
1:06
recognizing the heterogeneity of dlbcl
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
1:26
dr. woyach discusses peripheral lymphocytosis in patients with cll taking ibrutinib
-
2:00
dr. brander discusses the frontline treatment of cll
-
1:22
dr. chanan-khan discusses ibrutinib and br in cll
-
1:56
dr. abedin discusses key updates in cll
-
20:02
what are the hurdles to using cell of origin in classification to treat dlbcl?
-
1:53
dr. rosenblatt discusses promise of duvelisib in cll
-
0:55
the impact of mrd & genetics on outcomes to time-limited combinations in patients with cll
-
1:08
the history of understanding cll b-cell genes